Roche To Tailor Tamiflu Production As Supply Is Ample To Meet Demand
This article was originally published in The Pink Sheet Daily
Executive Summary
Supply of the antiviral significantly exceeds current orders for pandemic planning, Roche reports.
You may also be interested in...
Tamiflu Drags On Roche’s First Quarter Sales
Sales of Rituxan, Herceptin, Avastin and Boniva increase by double digits.
Tamiflu Drags On Roche’s First Quarter Sales
Sales of Rituxan, Herceptin, Avastin and Boniva increase by double digits.
Roche Hedges On U.S. Launch Of Mircera With November FDA Action Date Expected
Decision in Amgen’s patent infringement case against Roche over the continuous erythropoiesis receptor activator is expected in October.